2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
生物活性
Description
In Vivo
In Vitro
化合物的使用
Kinase Assay
Cell Assay
Animal Administration
参考文献
SAR 1118 is a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist for treating dry eye. For the detailed information of Lifitegrast(SAR 1118), the solubility of Lifitegrast(SAR 1118) in water, the solubility of Lifitegrast(SAR 1118) in DMSO, the solubility of Lifitegrast(SAR 1118) in PBS buffer, the animal experiment (test) of Lifitegrast(SAR 1118), the cell expriment (test) of Lifitegrast(SAR 1118), the in vivo, in vitro and clinical trial test of Lifitegrast(SAR 1118), the EC50, IC50,and affinity,of Lifitegrast(SAR 1118), For the detailed information of Lifitegrast(SAR 1118), the solubility of Lifitegrast(SAR 1118) in water, the solubility of Lifitegrast(SAR 1118) in DMSO, the solubility of Lifitegrast(SAR 1118) in PBS buffer, the animal experiment (test) of Lifitegrast(SAR 1118), the cell expriment (test) of Lifitegrast(SAR 1118), the in vivo, in vitro and clinical trial test of Lifitegrast(SAR 1118), the EC50, IC50,and affinity,of Lifitegrast(SAR 1118), Please contact DC Chemicals.
